Efficacy of HER2-targeted therapy in metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

Dorte L Nielsen, Iben Kümler, Jesper Andreas Palshof, Michael Andersson

80 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy of HER2-targeted therapy in metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases